CD8A and infection: In order to confirm that the predicted peptides could be recognized by T cells from individuals with previous infection with ZIKV and able to induce immune response, we stimulate PBMC of individuals with previous exposure to ZIKV with the pool of 13 CD8 and 12 CD4 peptides selected for the ZIKV vaccine.